| Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function A Viale, P Pettazzoni, CA Lyssiotis, H Ying, N Sánchez, M Marchesini, ... Nature 514 (7524), 628-632, 2014 | 1251 | 2014 |
| Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer T Arumugam, V Ramachandran, KF Fournier, H Wang, L Marquis, ... Cancer research 69 (14), 5820-5828, 2009 | 1036 | 2009 |
| Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy GR Varadhachary, EP Tamm, JL Abbruzzese, HQ Xiong, CH Crane, ... Annals of surgical oncology 13, 1035-1046, 2006 | 1018 | 2006 |
| International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer MI Canto, F Harinck, RH Hruban, GJ Offerhaus, JW Poley, I Kamel, Y Nio, ... Gut 62 (3), 339-347, 2013 | 875 | 2013 |
| Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head DB Evans, GR Varadhachary, CH Crane, CC Sun, JE Lee, PWT Pisters, ... Journal of Clinical Oncology 26 (21), 3496-3502, 2008 | 863 | 2008 |
| Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer A Kapoor, W Yao, H Ying, S Hua, A Liewen, Q Wang, Y Zhong, CJ Wu, ... Cell 158 (1), 185-197, 2014 | 751 | 2014 |
| Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases DG Blazer III, Y Kishi, DM Maru, S Kopetz, YS Chun, MJ Overman, ... Journal of Clinical Oncology 26 (33), 5344-5351, 2008 | 695 | 2008 |
| Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma CP Raut, JF Tseng, CC Sun, H Wang, RA Wolff, CH Crane, R Hwang, ... Annals of surgery 246 (1), 52-60, 2007 | 687 | 2007 |
| Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer JL Carstens, P Correa de Sampaio, D Yang, S Barua, H Wang, A Rao, ... Nature communications 8 (1), 15095, 2017 | 595 | 2017 |
| KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma J Ling, Y Kang, R Zhao, Q Xia, DF Lee, Z Chang, J Li, B Peng, JB Fleming, ... Cancer cell 21 (1), 105-120, 2012 | 567 | 2012 |
| Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators MHG Katz, JB Fleming, P Bhosale, G Varadhachary, JE Lee, R Wolff, ... Cancer 118 (23), 5749-5756, 2012 | 559 | 2012 |
| Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma MHG Katz, H Wang, JB Fleming, CC Sun, RF Hwang, RA Wolff, ... Annals of surgical oncology 16, 836-847, 2009 | 559 | 2009 |
| Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head GR Varadhachary, RA Wolff, CH Crane, CC Sun, JE Lee, PWT Pisters, ... Journal of clinical oncology 26 (21), 3487-3495, 2008 | 531 | 2008 |
| Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases D Ribero, H Wang, M Donadon, D Zorzi, MB Thomas, C Eng, DZ Chang, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 483 | 2007 |
| Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation H Wang, X Hu, M Huang, J Liu, Y Gu, L Ma, Q Zhou, X Cao Nature communications 10 (1), 1898, 2019 | 475 | 2019 |
| Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice MP Kim, DB Evans, H Wang, JL Abbruzzese, JB Fleming, GE Gallick Nature protocols 4 (11), 1670-1680, 2009 | 437 | 2009 |
| The crosstalk of mTOR/S6K1 and Hedgehog pathways Y Wang, Q Ding, CJ Yen, W Xia, JG Izzo, JY Lang, CW Li, JL Hsu, ... Cancer cell 21 (3), 374-387, 2012 | 407 | 2012 |
| Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer Y Chen, J Kim, S Yang, H Wang, CJ Wu, H Sugimoto, VS LeBleu, ... Cancer cell 39 (4), 548-565. e6, 2021 | 404 | 2021 |
| Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin‐associated liver lesions and partially prevented by bevacizumab in patients with … L Rubbia‐Brandt, GY Lauwers, H Wang, PE Majno, K Tanabe, A X Zhu, ... Histopathology 56 (4), 430-439, 2010 | 361 | 2010 |
| Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers Y Wei, W Xia, Z Zhang, J Liu, H Wang, NV Adsay, C Albarracin, D Yu, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 2008 | 348 | 2008 |
